AQR Capital Management LLC Decreases Stock Position in GE HealthCare Technologies Inc. $GEHC

Key Points

• AQR Capital Management LLC has reduced its stock position in GE HealthCare Technologies Inc. by 10.5%, owning 212,428 shares after selling 24,894 shares in the first quarter.
• Institutional investors currently own 82.06% of GE HealthCare Technologies, with several firms, including Bessemer Group Inc. and Flagship Harbor Advisors LLC, increasing their stakes significantly during the same period.
• Research analysts have a consensus rating of "Moderate Buy" for GE HealthCare Technologies, with a price target of $88.40, following quarterly earnings that exceeded expectations.

AQR Capital Management LLC reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 10.5% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 212,428 shares of the company's stock after selling 24,894 shares during the period. AQR Capital Management LLC's holdings in GE HealthCare Technologies were worth $17,011,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Breakwater Capital Group purchased a new stake in shares of GE HealthCare Technologies in the first quarter worth about $210,000. Bessemer Group Inc. boosted its stake in GE HealthCare Technologies by 24.3% in the first quarter. Bessemer Group Inc. now owns 6,671 shares of the company's stock worth $538,000 after buying an additional 1,306 shares in the last quarter. Flagship Harbor Advisors LLC boosted its stake in shares of GE HealthCare Technologies by 17.4% in the 1st quarter. Flagship Harbor Advisors LLC now owns 3,443 shares of the company's stock valued at $278,000 after purchasing an additional 511 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of GE HealthCare Technologies by 23.8% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 50,859 shares of the company's stock valued at $4,105,000 after buying an additional 9,769 shares during the last quarter. Finally, Farther Finance Advisors LLC grew its position in GE HealthCare Technologies by 52.7% during the 1st quarter. Farther Finance Advisors LLC now owns 4,493 shares of the company's stock worth $357,000 after acquiring an additional 1,550 shares during the last quarter. Institutional investors own 82.06% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on GEHC shares. Zacks Research upgraded shares of GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a report on Thursday, August 28th. BTIG Research reissued a "buy" rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Wall Street Zen raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, May 31st. Morgan Stanley cut their target price on GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating on the stock in a research note on Thursday, July 31st. Finally, Citigroup lifted their price target on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a "buy" rating in a research note on Thursday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $88.40.

GE HealthCare Technologies Trading Up 0.7%

Shares of GE HealthCare Technologies stock opened at $78.71 on Wednesday. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The business has a 50-day moving average price of $74.42 and a 200-day moving average price of $73.83. The firm has a market cap of $35.94 billion, a price-to-earnings ratio of 16.13, a PEG ratio of 2.99 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.15. The business had revenue of $5 billion for the quarter, compared to analysts' expectations of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The company's revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 25th were given a dividend of $0.035 per share. The ex-dividend date was Friday, July 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio is 2.87%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.